SUZHOU KEMATEK INC (301611) fair value: what the stock is really worth
As of Oct 23, 2026: fair value (intrinsic value) of SUZHOU KEMATEK INC stock ¥15.79, price ¥67.47, upside -76.6%, quality 36 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value above price?No
Good quality?No
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 25, 2026.
How to read this chart
26‑month range ¥27.40 – ¥184.48 · fair‑value band ¥11.83 – ¥19.73 · the ¥67.47 price screens above the ¥15.79 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 25, 2026.
Follow SUZHOU KEMATEK in your weekly email
Every Wednesday you see whether SUZHOU KEMATEK is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Suzhou KemaTek, Inc. engages in the research, development, manufacturing, and sales of various ceramic components in China and internationally. The company offers oxide, nitride, carbide, and machinable ceramics; surface treatment services; and metal structural components.
Show moreShow less
Its products are applied in advanced equipment manufacturing, mechanical equipment, medical and pharmaceutical, new energy, electronic communications, as well as auto, textile, and chemical industries. The company was founded in 2009 and is headquartered in Suzhou, China.
Stock analysis
SUZHOU KEMATEK INC (301611) currently trades at ¥67.47, while our model-based Fair Value estimate is ¥15.79, 76.6% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥28.55 per share, and 0 of the 14 models we run sit above the ¥67.47 price.
Bear case: the Economic Profit group reads lowest at ¥5.62, and 14 of the 14 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ¥11.83 (bear) to ¥19.73 (bull), the price of ¥67.47 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Technology sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
SUZHOU KEMATEK INC reported revenue of 1.1B CNY in FY2025 versus 345M CNY in FY2021, a compound +32.8%/yr. Reported net income was 289M CNY in FY2025, compounding +44.1%/yr from FY2021.
Key figures
Market cap 29.4B CNY (≈ $4.4B) Mid · P/E ratio 137.7 · P/S ratio 25.7 · EPS (TTM) ¥0.4900 · Dividend yield 0.1% · Net margin 18.8% · Return on equity 11.2% · Return on assets (EBIT) 11.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 63 out of 100 (low confidence).
What moves the price
The share trades about 63% below its 52-week high and 35% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −5% fair-value upside, at −77%, 301611 screens richer than that median.
Fair Value models
The price assumes far more growth than our models allow for, so the models scatter widely (¥1.13 to ¥31.44). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear¥11.83Fair Value ¥15.79Bull¥19.73
Price ¥67.47 · Upside -76.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.3184 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV¥7.09¥8.15¥9.0774
Residual Income¥4.23¥5.62¥9.0672
ROIC Compounder¥9.46¥14.48¥17.5370
All 14 models by family
Earnings-Based
Graham-Dodd¥4.51¥31.44¥44.1361
Lynch FV¥16.24¥23.21¥30.1759
PEG = 1.0¥16.24¥23.21¥30.1755
EPV¥7.09¥8.15¥9.0774
Multiples
P/E Multiple¥8.45¥11.27¥14.0963
P/S Multiple¥2.77¥3.69¥4.6258
P/B Multiple¥8.69¥11.59¥14.4855
EV/EBIT¥9.13¥12.03¥14.9266
EV/EBITDA¥8.18¥10.76¥13.3467
EV/Revenue¥3.03¥4.14¥5.2554
Asset-Based
NCAV (Graham)¥0.7400¥1.13¥1.4154
Economic Profit
Residual Income¥4.23¥5.62¥9.0672
ROIC Compounder¥9.46¥14.48¥17.5370
Growth Earnings
Growth-Adj P/E¥19.99¥28.55¥37.1265
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.57/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+25.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+33.4%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+35.2%
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+34.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+34.7%
Dividend (yield on the price)0.1%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.21% → 34%
2025 sits 157% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductor Equipment & Materials · 227 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is SUZHOU KEMATEK INC (301611) overvalued or undervalued?
As of Oct 25, 2026, our model estimates a fair value of ¥15.79 versus a price of ¥67.47, about −77% upside (overvalued).
What is the fair value of 301611?
Our model-based fair value for SUZHOU KEMATEK INC is ¥15.79 (as of Oct 25, 2026), built from audited fundamentals. The current price: ¥67.47.
What is the quality score of 301611?
SUZHOU KEMATEK INC has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for SUZHOU KEMATEK INC (301611)?
Our model-based price target is the fair value of ¥15.79 (as of Oct 25, 2026) from 14 valuation models. Cautious scenario ¥11.83, optimistic scenario ¥19.73. It is a calculation from audited fundamentals, not an analyst target.
What is the SUZHOU KEMATEK INC stock forecast for 2026?
Our models put fair value at ¥15.79, about −77% upside versus a price of ¥67.47 (overvalued). Cautious scenario ¥11.83, optimistic scenario ¥19.73. The calculation is refreshed regularly with new filings.
What is the revenue of SUZHOU KEMATEK INC (301611)?
SUZHOU KEMATEK INC reported trailing-twelve-month revenue of about 1.1B CNY (latest available figure, as of Oct 25, 2026).
Does SUZHOU KEMATEK INC pay a dividend?
SUZHOU KEMATEK INC currently shows a dividend yield of 0.15% relative to its recent price (as of Oct 25, 2026).
What is the intrinsic value of SUZHOU KEMATEK INC (301611)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For SUZHOU KEMATEK INC it is ¥15.79 per share (as of Oct 25, 2026), against a price of ¥67.47. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is SUZHOU KEMATEK INC stock overvalued or undervalued in 2026?
As of Oct 25, 2026, 301611 trades above its calculated fair value: price ¥67.47, fair value ¥15.79, a gap of about −77% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 301611?
No. The price is what the market pays today (¥67.47); the fair value is what the company's own numbers justify (¥15.79). For SUZHOU KEMATEK INC the two are ¥51.69 per share apart. That gap is exactly why we show both numbers side by side.
How much is SUZHOU KEMATEK INC worth?
The market values SUZHOU KEMATEK INC at about 29.4B CNY (market capitalisation, as of Oct 25, 2026). Per share that is ¥67.47; our models calculate a fair value of ¥15.79 per share.
What do the bullish and bearish scenarios say about 301611?
Our models span a range for SUZHOU KEMATEK INC: cautious scenario ¥11.83, base ¥15.79, optimistic ¥19.73 per share (as of Oct 25, 2026, price ¥67.47). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 301611?
SUZHOU KEMATEK INC trades at a price-to-earnings ratio of 137.7 (as of Oct 25, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥15.79 is built from several models across several years. Other multiples: P/B 16.6, P/S 25.7, EV/EBITDA 91.1.
How solid is the balance sheet of SUZHOU KEMATEK INC (301611)?
Balance-sheet figures for SUZHOU KEMATEK INC (as of Oct 25, 2026): return on equity 11.2%, debt of 0.08 per unit of equity. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is 301611 from its 52-week high?
SUZHOU KEMATEK INC trades at ¥67.47, about 63% below its 52-week high of ¥184.48 and 35% above the low of ¥50.03 (as of Oct 23, 2026). Distance from the high says nothing about value: that is what the fair value of ¥15.79 is for.
Which stocks are comparable to SUZHOU KEMATEK INC?
From the same area (Technology) we also value ASML Holding, Lam Research Corporation, Applied Materials, Inc, KLA Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is SUZHOU KEMATEK INC stock attractive at the current price?
The data as of Oct 25, 2026: price ¥67.47, calculated fair value ¥15.79 (−77%), Quality Score 36/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 301611 calculated?
We run SUZHOU KEMATEK INC through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥15.79, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3 % above its aggregate fair value. SUZHOU KEMATEK INC itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of SUZHOU KEMATEK INC (301611)?
The closing price on Oct 23, 2026 was ¥67.47. Our model-based fair value is ¥15.79, about −77% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with SUZHOU KEMATEK INC right now?
The price sits above even our optimistic bull case (¥19.73). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts.
Key figures of SUZHOU KEMATEK INC
How large is the market capitalisation of SUZHOU KEMATEK INC (301611)?
The market capitalisation of SUZHOU KEMATEK INC is 29.4B CNY (≈ $4.4B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of SUZHOU KEMATEK INC (301611)?
The price-to-sales ratio of SUZHOU KEMATEK INC is 25.7 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of SUZHOU KEMATEK INC (301611)?
Earnings per share at SUZHOU KEMATEK INC are ¥0.4900 (price ÷ EPS = P/E 137.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of SUZHOU KEMATEK INC (301611)?
The dividend yield of SUZHOU KEMATEK INC is 0.1% (payout 20.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of SUZHOU KEMATEK INC (301611)?
The net margin of SUZHOU KEMATEK INC is 18.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of SUZHOU KEMATEK INC (301611)?
The return on equity (ROE) of SUZHOU KEMATEK INC is 11.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of SUZHOU KEMATEK INC (301611)?
On an EBIT basis the return on assets of SUZHOU KEMATEK INC is 11.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of SUZHOU KEMATEK INC (301611)?
The operating margin of SUZHOU KEMATEK INC is 14.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at SUZHOU KEMATEK INC (301611)?
Revenue at SUZHOU KEMATEK INC is growing +18.1% versus a year earlier (3y avg +32.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at SUZHOU KEMATEK INC (301611)?
Earnings per share at SUZHOU KEMATEK INC are growing −42.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does SUZHOU KEMATEK INC (301611) generate?
The free cash flow of SUZHOU KEMATEK INC is −45.8M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does SUZHOU KEMATEK INC (301611) hold?
SUZHOU KEMATEK INC holds more cash than debt, 196M CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch SUZHOU KEMATEK INC in the live analysis
One click puts SUZHOU KEMATEK INC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Some data
Oct 25, 2026